The consequences of COVID-19 pandemic on patients with monoclonal gammopathy-associated systemic capillary leak syndrome (Clarkson disease).

MLA

Pineton de Chambrun, Marc, et al. “The Consequences of COVID-19 Pandemic on Patients with Monoclonal Gammopathy-Associated Systemic Capillary Leak Syndrome (Clarkson Disease).” The Journal of Allergy and Clinical Immunology. In Practice, vol. 10, no. 2, Feb. 2022, pp. 626–29. EBSCOhost, https://doi.org/10.1016/j.jaip.2021.11.023.

APA

Pineton de Chambrun, M., Moyon, Q., Faguer, S., Urbanski, G., Mathian, A., Zucman, N., Werner, M., Luyt, C.-E., Verlicchi, F., & Amoura, Z. (2022). The consequences of COVID-19 pandemic on patients with monoclonal gammopathy-associated systemic capillary leak syndrome (Clarkson disease). The Journal of Allergy and Clinical Immunology. In Practice, 10(2), 626–629. https://doi.org/10.1016/j.jaip.2021.11.023

Chicago

Pineton de Chambrun, Marc, Quentin Moyon, Stanislas Faguer, Geoffrey Urbanski, Alexis Mathian, Noémie Zucman, Marie Werner, Charles-Edouard Luyt, Franco Verlicchi, and Zahir Amoura. 2022. “The Consequences of COVID-19 Pandemic on Patients with Monoclonal Gammopathy-Associated Systemic Capillary Leak Syndrome (Clarkson Disease).” The Journal of Allergy and Clinical Immunology. In Practice 10 (2): 626–29. doi:10.1016/j.jaip.2021.11.023.